Broad clinical high-risk mental state (CHARMS): Methodology of a cohort study validating criteria for pluripotent risk.


Journal

Early intervention in psychiatry
ISSN: 1751-7893
Titre abrégé: Early Interv Psychiatry
Pays: Australia
ID NLM: 101320027

Informations de publication

Date de publication:
06 2019
Historique:
received: 22 02 2017
revised: 08 06 2017
accepted: 17 07 2017
pubmed: 7 10 2017
medline: 26 11 2019
entrez: 7 10 2017
Statut: ppublish

Résumé

The development of the ultra-high risk (UHR) criteria for psychosis created a new paradigm for the prevention research in psychiatry. Since (1) prevention research faces the challenge of achieving adequate statistical power when focusing on single low-incidence syndromes and (2) early clinical phenotypes are overlapping and non-specific, this study broadens the UHR state beyond psychosis as an outcome. The CHARMS (clinical high at-risk mental state) study aims to prospectively validate a set of trans-diagnostic criteria to identify help-seeking young people at risk of developing a range of serious mental illnesses. This paper describes the methodology of the CHARMS study, which involves applying the CHARMS criteria to a cohort of help-seeking young people aged 12 to 25 attending youth mental health services in Melbourne. New referrals meeting the CHARMS criteria are allocated to the CHARMS+ group; referrals not meeting CHARMS threshold are allocated to CHARMS- group (control group); referrals meeting criteria for a full-threshold disorder are excluded. Transition status and clinical and functional outcomes are re-assessed at 6 and 12 months. This study will be the first to introduce and validate clinical criteria to identify a broader at-risk patient population, which may facilitate young people's access to clinical services and early treatment by reducing the reliance on "caseness" defined according to current diagnostic categories being required for service entry. These criteria may introduce a new, trans-diagnostic approach for understanding risk factors and pathogenic mechanisms that drive the onset of severe mental illness and the next generation of preventive intervention trials.

Identifiants

pubmed: 28984077
doi: 10.1111/eip.12483
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

379-386

Subventions

Organisme : John T Reid Charitable Trusts
Pays : International
Organisme : Colonial Foundation
Pays : International

Informations de copyright

© 2017 John Wiley & Sons Australia, Ltd.

Auteurs

Jessica A Hartmann (JA)

Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, Australia.
Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

Barnaby Nelson (B)

Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, Australia.
Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

Rachael Spooner (R)

Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, Australia.
Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

G Paul Amminger (G)

Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, Australia.
Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

Andrew Chanen (A)

Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, Australia.
Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

Christopher G Davey (CG)

Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, Australia.
Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

Meredith McHugh (M)

Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, Australia.
Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

Aswin Ratheesh (A)

Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, Australia.
Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

Devi Treen (D)

Institute of Neuropsychiatry and Addictions (INAD) - Parc de Salut Mar Barcelona, Barcelona, Spain.

Hok Pan Yuen (HP)

Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, Australia.
Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

Patrick D McGorry (PD)

Orygen, the National Centre of Excellence in Youth Mental Health, Melbourne, Australia.
Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH